This inventor holds 4 USPTO granted patents and 3 EPO patents. Top assignee: Nippon Shinyaku Company, Ltd.. Active years: 2010-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Tsukuba, JP (2010 - 2013)
- Ibaraki, JP (2015)
Company Filing History:
Years Active: 2010-2015
Title: The Innovations of Toshihiro Ueda
Introduction
Toshihiro Ueda is a prominent inventor based in Tsukuba, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of nucleic acid derivatives and drug carriers. With a total of 4 patents to his name, Ueda's work has the potential to impact various medical applications.
Latest Patents
Ueda's latest patents include innovative advancements in morpholino nucleic acid derivatives. This invention provides a useful morpholino nucleic acid derivative for synthesizing a morpholino nucleic acid oligomer. The compound is represented by a specific general formula, where R can represent hydrogen, trityl, and other groups. Additionally, Ueda has developed a novel polyethylene glycol derivative, which serves as a drug carrier. This derivative is part of a pharmaceutical composition that includes a pharmacologically active substance, such as double-stranded RNA or DNA.
Career Highlights
Toshihiro Ueda is currently associated with Nippon Shinyaku Company, Ltd., where he continues to innovate in the field of biotechnology. His work focuses on creating effective drug delivery systems that can enhance the efficacy of therapeutic agents.
Collaborations
Ueda has collaborated with notable colleagues, including Tadaaki Ohgi and Satoru Sonoke. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Toshihiro Ueda's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical science and drug delivery systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile